Patient Centricity

The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality

Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand greater transparency, the pharmaceutical industry is undergoing a profound transformation in terms of patient centricity. Our latest white paper, “The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality,” explores how patient centricity has shifted from…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Racial and Ethnic Diversity in Pharma and Clinical Trials

Racial and Ethnic Diversity in Pharma and Clinical Trials

CACTUS strongly supports inclusion and diversity and is working hard to raise awareness about this...
DE&I Infographic #1

The Business Case for Diversity, Equity, and Inclusion (DE&I) in the Pharma Industry

To learn how much businesses can gain from more diverse and inclusive workplaces and why...

Engagement Strategies for the Digitally Savvy HCP

An infographic on engagement strategies for digitally savvy HCPs (Healthcare Professionals), by Cactus Life Sciences...
Plain language summaries

3 Interesting Facts about Plain Language Summaries

Did you know these 3 facts about plain language summaries?...

World Patient Safety Day September 17, 2021 – Safe Maternal and Newborn Care

This World Patient Safety Day, let's make maternal and newborn care a global health priority...
Pexels Alexander Suhorucov

Plain Language Summary Development in Japan: Current State and Challenges

This page contains supplementary information to support a poster presented at the Virtual 17th Annual...

Learn more ABOUT our company.